OncoInsight Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 14

Employees

  • Latest Deal Type
  • Series B

  • Investors
  • 10

OncoInsight General Information

Description

Operator of a biotechnology company intended to develop a CAR-NK cell therapy that targets blood cancer or solid cancer using natural killer cells. The company offers accessible cell therapies to increase the killing power of NK cells by expressing a CAR protein engineered to bind only to cancer cells in NK cells that differentiate and attack only cancer cells, enabling clinicians to overcome the limitations of CAR-T treatment.

Contact Information

Website
www.oncoinsight.co.kr
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 281, Gwangpyeong-ro
  • Gangnam-gu
  • Seoul, 06349
  • South Korea
+82
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 281, Gwangpyeong-ro
  • Gangnam-gu
  • Seoul, 06349
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OncoInsight Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series B) 05-Mar-2023 Completed Generating Revenue
3. Accelerator/Incubator 21-May-2024 Completed Generating Revenue
2. Early Stage VC (Series A) 25-Jul-2021 $18.6M $21.2M Completed Generating Revenue
1. Seed Round 04-Feb-2020 $2.56M $2.56M Completed Generating Revenue
To view OncoInsight’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

OncoInsight Patents

  • 5

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 1

    Pending

  • Expiring in next 12 mo

OncoInsight Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026005479-A1 Method for producing natural killer cells and car-nk cells, natural killer cells and car-nk cells produced thereby, and use thereof Pending 25-Jun-2024
WO-2023249396-A1 Macrophages derived from induced pluripotent stem cells, preparation method therefor, and use thereof Inactive 24-Jun-2022
WO-2022145832-A1 Induced pluripotent stem cell-derived natural killer cell and use thereof Inactive 29-Dec-2020
WO-2022108165-A1 Method for producing exosomes isolated from induced pluripotent stem cell-derived mesenchymal stem cells, and use thereof Inactive 18-Nov-2020
WO-2020180065-A1 Method for preparation of natural killer cell in cord blood monocyte Inactive 05-Mar-2019 C12N5/0646
To view OncoInsight’s complete patent history, request access »

OncoInsight Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OncoInsight Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Seoul Biohub Accelerator/Incubator
Envester Venture Capital Minority
KB Securities Investment Bank Minority
Rico Asset Management Asset Manager Minority
SBI Investment Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

Ready to get started?

Request a free trial

OncoInsight FAQs

  • When was OncoInsight founded?

    OncoInsight was founded in 2017.

  • Where is OncoInsight headquartered?

    OncoInsight is headquartered in Seoul, South Korea.

  • What is the size of OncoInsight?

    OncoInsight has 14 total employees.

  • What industry is OncoInsight in?

    OncoInsight’s primary industry is Biotechnology.

  • Is OncoInsight a private or public company?

    OncoInsight is a Private company.

  • What is OncoInsight’s current revenue?

    The current revenue for OncoInsight is .

  • How much funding has OncoInsight raised over time?

    OncoInsight has raised $21.2M.

  • Who are OncoInsight’s investors?

    Seoul Biohub, Envester, KB Securities, Rico Asset Management, and SBI Investment are 5 of 10 investors who have invested in OncoInsight.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process